Abstract
Tumor recurrence and metastasis are the major causes of death for hepatocellular carcinoma (HCC) patients who are able to receive curative resection. Identifying the predicting biomarkers for tumor recurrence would improve their survival. RNA extracted from fresh frozen tumors and adjacent non-tumor liver tissues of 120 HCC patients were obtained from Taiwan Liver Cancer Network (TLCN) in year 2010 for determination of the carboxypeptidase E (CPE) expression level (including its splicing mutant CPE-ΔN) in the tumor tissue (T) and paired non-tumor liver tissue (N) by real-time quantitative polymerase chain reaction. All patients were male, had chronic hepatitis B virus infection, were in the early pathology stage, and received curative resection. The T/N ratio of the CPE expression level was correlated with the updated survival data from TLCN in 2015. The CPE expression level in the 120 HCC patients was divided into three groups according to the T/N ratio: <1, ≥1 and ≤2, and >2, respectively. By multivariate analyses, the recurrence-free survival (RFS) was only significantly associated with the pathology stage and the CPE expression level. For overall survival (OS), only the CPE expression level was the significant prognostic fa...Continue Reading
References
Apr 15, 1990·The Biochemical Journal·E ManserL Lim
Jan 1, 1988·Annual Review of Physiology·L D Fricker
Jan 10, 1997·Cell·D R CoolY P Loh
Jul 18, 2000·The Journal of Biological Chemistry·S Dhanvantari, Y P Loh
May 28, 2004·Endocrine-related Cancer·X-C WangR-M Hu
Oct 20, 2004·Human Pathology·Ping HeCurtis C Harris
May 27, 2005·Seminars in Liver Disease·Josep M LlovetVincenzo Mazzaferro
Jun 16, 2007·Gastroenterology·Hashem B El-Serag, K Lenhard Rudolph
Feb 12, 2009·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Ming-Wei LaiChau-Ting Yeh
Dec 17, 2009·Surgery·Divya DahiyaMiin-Fun Chen
Feb 25, 2010·Annals of Surgical Oncology·Stephen B Edge, Carolyn C Compton
Apr 21, 2010·Annals of Surgical Oncology·William R Jarnagin
Nov 10, 2010·Cellular and Molecular Neurobiology·Saravana R K MurthyY Peng Loh
Feb 3, 2011·The Journal of Clinical Investigation·Terence K LeeY Peng Loh
Oct 19, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Shinji TanakaShigeki Arii
Jan 18, 2012·Acta Neuropathologica·Elisabeth HöringUlrike Naumann
Feb 23, 2012·Lancet·Alejandro FornerJordi Bruix
Mar 10, 2012·Endocrine Reviews·Niamh X CawleyY Peng Loh
Dec 12, 2012·PloS One·Jianxiong WuChunfeng Qu
Jan 4, 2013·PloS One·Hai-Tao ZhuLun-Xiu Qin
Jul 16, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Kun ZhouXiaofeng Jiang
Aug 15, 2013·Cancer Letters·Saravana R K MurthyY Peng Loh
Aug 27, 2013·PloS One·Yong ChengY Peng Loh
Sep 7, 2013·BMC Cancer·Xing-Hua LiangXian-Cheng Zeng
Oct 22, 2014·Molecular Psychiatry·Y ChengY P Loh
Nov 5, 2014·Seminars in Liver Disease·Li-Chun LuRonnie T P Poon
Citations
Jun 30, 2016·PloS One·Yvonne S ZieglerAnn M Nardulli
Jun 8, 2017·Analytical Chemistry·Feihua CaoChristopher J Easton
Nov 22, 2017·PeerJ·Zeting QiuWenqi Huang
Nov 17, 2019·International Journal of Molecular Sciences·Sangeetha HareendranY Peng Loh
Dec 5, 2019·Genes & Cancer·Xuyu YangY Peng Loh
Jul 18, 2020·Cancer Biomarkers : Section a of Disease Markers·Zhile BaiYong Cheng
Oct 24, 2017·ACS Medicinal Chemistry Letters·Sebastián A TesteroShahriar Mobashery